Lin Chan represents consumers, small businesses, and employees in class actions involving antitrust, fraud, discrimination, and wage theft. Lin has represented California consumers and third party payors of Cipro in a class action charging that brand name and generic prescription drug manufacturers conspired to restrain competition in the sale of Bayer’s blockbuster antibiotic drug Cipro. Total settlements in the case reached $399 million. Lin has also represented consumers in a class action filed against lithium ion battery manufacturers for conspiring to fix the prices of lithium ion batteries, as well as direct purchasers of titanium dioxide against titanium dioxide manufacturers for conspiring to fix prices. In 2017, Lin won the prestigious award for “Outstanding Antitrust Achievement by a Young Lawyer” from the American Antitrust Institute for her work on the Cipro drug antitrust cases, as well as sharing Lieff Cabraser’s team award from the AAI for “Outstanding Private Practice Antitrust Achievement” for their work on the Cipro case. Lin chairs the Antitrust and Business Regulation Section of the Bar Association of San Francisco and serves as Secretary of the Committee to Support the Antitrust Laws. She previously served as a law clerk to the Honorable Damon J. Keith of the Sixth Circuit U.S. Court of Appeals from 2007 to 2008. While at Stanford, Lin was the Editor-in-Chief of the Stanford Journal of Civil Rights and Civil Liberties.
Bill Isaacson, a partner in the Litigation Department of Paul, Weiss, Rifkind, Wharton & Garrison LLP, is widely considered one of the most preeminent litigators of his generation. A Fellow of the American College of Trial Lawyers, Bill was named a “Litigator of the Year” in 2016 and a “Litigator of the Week” three times by The American Lawyer. Chambers has called Bill a “celebrated trial lawyer” who is “highly recommended for his work in complex class actions.”
Bill has successfully represented both plaintiffs and defendants in major antitrust litigations; of the approximately dozen federal antitrust class actions that have gone to trial and judgment in this century, he has tried five of them, winning verdicts in each case. Global Competition Review has noted that “arguably no antitrust lawyer in recent memory has had as much success for both plaintiffs and defendants as Bill Isaacson.” Lawdragon writes that it is “nearly impossible to find a more reliable antitrust litigator than Isaacson, who has successfully handled several of the most high-profile cases in the past two decades.”